Eversept Partners LP bought a new stake in shares of Omega Healthcare Investors Inc (NYSE:OHI) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 41,400 shares of the real estate investment trust’s stock, valued at approximately $1,521,000.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Krane Funds Advisors LLC bought a new position in Omega Healthcare Investors during the 2nd quarter valued at about $25,000. Coastal Investment Advisors Inc. lifted its stake in Omega Healthcare Investors by 148.4% during the 2nd quarter. Coastal Investment Advisors Inc. now owns 683 shares of the real estate investment trust’s stock valued at $26,000 after acquiring an additional 408 shares during the period. Redhawk Wealth Advisors Inc. bought a new position in Omega Healthcare Investors during the 2nd quarter valued at about $31,000. Kavar Capital Partners LLC bought a new position in Omega Healthcare Investors during the 2nd quarter valued at about $33,000. Finally, Avestar Capital LLC lifted its stake in Omega Healthcare Investors by 63.2% during the 1st quarter. Avestar Capital LLC now owns 1,286 shares of the real estate investment trust’s stock valued at $49,000 after acquiring an additional 498 shares during the period. Institutional investors and hedge funds own 69.94% of the company’s stock.
Shares of NYSE OHI traded up $0.34 during midday trading on Friday, hitting $41.50. 2,132 shares of the company’s stock traded hands, compared to its average volume of 1,877,067. Omega Healthcare Investors Inc has a 1 year low of $31.69 and a 1 year high of $41.67. The stock has a market capitalization of $8.77 billion, a price-to-earnings ratio of 13.65, a price-to-earnings-growth ratio of 5.33 and a beta of 0.37. The company has a debt-to-equity ratio of 1.17, a quick ratio of 2.78 and a current ratio of 2.78. The firm has a fifty day moving average of $38.95 and a 200 day moving average of $37.18.
Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.34 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.73 by ($0.39). The business had revenue of $191.81 million for the quarter, compared to analysts’ expectations of $190.46 million. Omega Healthcare Investors had a net margin of 29.38% and a return on equity of 6.79%. Omega Healthcare Investors’s revenue for the quarter was down .5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.75 EPS. On average, equities analysts anticipate that Omega Healthcare Investors Inc will post 2.96 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Wednesday, July 31st were issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 6.36%. The ex-dividend date was Tuesday, July 30th. Omega Healthcare Investors’s dividend payout ratio is 86.84%.
In other Omega Healthcare Investors news, COO Daniel J. Booth sold 20,000 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $40.24, for a total transaction of $804,800.00. Following the completion of the sale, the chief operating officer now directly owns 178,241 shares of the company’s stock, valued at approximately $7,172,417.84. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Robert O. Stephenson sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $38.00, for a total transaction of $380,000.00. Following the sale, the chief financial officer now directly owns 223,326 shares of the company’s stock, valued at $8,486,388. The disclosure for this sale can be found here. Insiders sold a total of 118,500 shares of company stock valued at $4,586,300 over the last three months. 1.16% of the stock is currently owned by insiders.
Several equities research analysts have recently commented on OHI shares. Raymond James upped their price target on shares of Omega Healthcare Investors from $42.00 to $44.00 and gave the company a “strong-buy” rating in a research report on Thursday. Wells Fargo & Co upped their price target on shares of Omega Healthcare Investors from $36.00 to $40.00 and gave the company a “market perform” rating in a research report on Friday, August 23rd. Zacks Investment Research lowered shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research report on Wednesday, August 21st. Finally, Berenberg Bank started coverage on shares of Omega Healthcare Investors in a research report on Thursday. They set a “buy” rating and a $47.00 price target for the company. Seven equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $40.04.
Omega Healthcare Investors Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Read More: What is an investor looking for in an SEC filing?
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.